Canopy Growth (CGC) Return on Capital Employed Growth (1y) (2021 - 2025)
Canopy Growth (CGC) Return on Capital Employed Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.52 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 1,195.00 |
| 10 | Canopy Growth | 275.81 Mn | 9.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 637.00 |
| Sep 30, 2025 | 1,385.00 |
| Jun 30, 2025 | 357.00 |
| Dec 31, 2024 | 3,229.00 |
| Sep 30, 2024 | 1,554.00 |
| Jun 30, 2024 | 2,723.00 |
| Mar 31, 2024 | 12,401.00 |
| Dec 31, 2023 | 5,656.00 |
| Sep 30, 2023 | 5,055.00 |
| Jun 30, 2023 | 1,793.00 |
| Mar 31, 2023 | -12,928.00 |
| Dec 31, 2022 | -9,555.00 |
| Sep 30, 2022 | -7,433.00 |
| Jun 30, 2022 | -4,600.00 |
| Mar 31, 2022 | 153.00 |
| Dec 31, 2021 | 1,805.00 |
| Sep 30, 2021 | 814.00 |
| Jun 30, 2021 | 593.00 |
| Mar 31, 2021 | 3,364.00 |